ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
81.51
+6.82 (9.13%)
Mar 31, 2026, 4:00 PM EDT - Market closed
BIB Holdings Information
BIB is an equity ETF with a total of 266 individual holdings.
Total Holdings
266
Top 10 Percentage
149.63%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
73.05M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 32.34% |
| 2 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 28.04% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 27.95% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 19.93% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 15.03% |
| 6 | GILD | Gilead Sciences, Inc. | 5.70% |
| 7 | AMGN | Amgen Inc. | 5.60% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 5.55% |
| 9 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.78% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 4.71% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.54% |
| 12 | INSM | Insmed Incorporated | 2.00% |
| 13 | BIIB | Biogen Inc. | 1.66% |
| 14 | UTHR | United Therapeutics Corporation | 1.56% |
| 15 | ARGX | argenx SE | 1.21% |
| 16 | RPRX | Royalty Pharma plc | 1.20% |
| 17 | MRNA | Moderna, Inc. | 1.15% |
| 18 | ROIV | Roivant Sciences Ltd. | 1.14% |
| 19 | ILMN | Illumina, Inc. | 1.12% |
| 20 | RVMD | Revolution Medicines, Inc. | 1.11% |
| 21 | INCY | Incyte Corporation | 1.09% |
| 22 | VTRS | Viatris Inc. | 0.90% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.81% |
| 24 | ASND | Ascendis Pharma A/S | 0.81% |
| 25 | SMMT | Summit Therapeutics Inc. | 0.80% |
As of Mar 30, 2026